(MHO) M/I Homes - Overview
Stock: Residential Homes, Townhomes, Land Development, Mortgages
| Risk 5d forecast | |
|---|---|
| Volatility | 37.6% |
| Relative Tail Risk | -3.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -4.08 |
| Character TTM | |
|---|---|
| Beta | 1.098 |
| Beta Downside | 1.753 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.60% |
| CAGR/Max DD | 0.81 |
EPS (Earnings per Share)
Revenue
Description: MHO M/I Homes February 28, 2026
M/I Homes, Inc. (NYSE: MHO) builds and sells single-family homes and attached townhomes across nine U.S. states, operating through its Northern Homebuilding, Southern Homebuilding, and Financial Services segments. The firm also acquires undeveloped land for future construction, originates mortgages, and provides title-insurance and closing services under the M/I Homes brand.
In its most recent Q2 2024 earnings release, M/I Homes reported revenue of $1.12 billion, a net income of $45 million, and an average selling price of $360 k per home, reflecting a 5% year-over-year increase in pricing. The company’s construction backlog stood at $1.22 billion, while land acquisitions added roughly $150 million of undeveloped lots, supporting pipeline growth for the back half of 2024.
Key drivers for the homebuilding sector remain strong demand from first-time and move-up buyers, a tight housing inventory that keeps supply constrained, and mortgage rates that have stabilized around 6.8% after a period of volatility. Additionally, favorable demographic trends-particularly the aging-millennial cohort entering peak home-buying years-continue to underpin demand in MHO’s core markets.
For a deeper dive into how these dynamics translate into valuation metrics, you might want to explore ValueRay’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 402.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.12 > 1.0 |
| NWC/Revenue: 86.75% < 20% (prev 89.18%; Δ -2.43% < -1%) |
| CFO/TA 0.03 > 3% & CFO 136.9m > Net Income 402.9m |
| Net Debt (397.3m) to EBITDA (623.6m): 0.64 < 3 |
| Current Ratio: 7.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (26.8m) vs 12m ago -6.24% < -2% |
| Gross Margin: 23.04% > 18% (prev 0.27%; Δ 2277 % > 0.5%) |
| Asset Turnover: 94.37% > 50% (prev 98.93%; Δ -4.56% > 0%) |
| Interest Coverage Ratio: 6.97 > 6 (EBITDA TTM 623.6m / Interest Expense TTM 86.6m) |
Altman Z'' 10.00
| A: 0.80 (Total Current Assets 4.38b - Total Current Liabilities 552.1m) / Total Assets 4.81b |
| B: 0.68 (Retained Earnings 3.27b / Total Assets 4.81b) |
| C: 0.13 (EBIT TTM 603.6m / Avg Total Assets 4.68b) |
| D: 1.99 (Book Value of Equity 3.27b / Total Liabilities 1.64b) |
| Altman-Z'' Score: 10.40 = AAA |
Beneish M
| DSRI: none (Receivables none/none, Revenue 4.42b/4.50b) |
| GMI: 1.15 (GM 23.04% / 26.56%) |
| AQI: 1.77 (AQ_t 0.07 / AQ_t-1 0.04) |
| SGI: 0.98 (Revenue 4.42b / 4.50b) |
| TATA: 0.06 (NI 402.9m - CFO 136.9m) / TA 4.81b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of MHO shares?
Over the past week, the price has changed by -4.60%, over one month by -4.40%, over three months by +3.53% and over the past year by +11.55%.
Is MHO a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MHO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 157 | 15.8% |
| Analysts Target Price | 157 | 15.8% |
MHO Fundamental Data Overview March 05, 2026
P/E Forward = 10.2881
P/S = 0.8417
P/B = 1.1507
P/EG = 0.954
Revenue TTM = 4.42b USD
EBIT TTM = 603.6m USD
EBITDA TTM = 623.6m USD
Long Term Debt = 973.2m USD (from longTermDebt, last quarter)
Short Term Debt = 289.7m USD (from shortTermDebt, last quarter)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 397.3m USD (from netDebt column, last quarter)
Enterprise Value = 4.12b USD (3.72b + Debt 1.09b - CCE 689.2m)
Interest Coverage Ratio = 6.97 (Ebit TTM 603.6m / Interest Expense TTM 86.6m)
EV/FCF = 32.35x (Enterprise Value 4.12b / FCF TTM 127.2m)
FCF Yield = 3.09% (FCF TTM 127.2m / Enterprise Value 4.12b)
FCF Margin = 2.88% (FCF TTM 127.2m / Revenue TTM 4.42b)
Net Margin = 9.13% (Net Income TTM 402.9m / Revenue TTM 4.42b)
Gross Margin = 23.04% ((Revenue TTM 4.42b - Cost of Revenue TTM 3.40b) / Revenue TTM)
Gross Margin QoQ = 18.10% (prev 24.10%)
Tobins Q-Ratio = 0.86 (Enterprise Value 4.12b / Total Assets 4.81b)
Interest Expense / Debt = 4.91% (Interest Expense 53.3m / Debt 1.09b)
Taxrate = 20.59% (16.6m / 80.6m)
NOPAT = 479.3m (EBIT 603.6m * (1 - 20.59%))
Current Ratio = 7.94 (Total Current Assets 4.38b / Total Current Liabilities 552.1m)
Debt / Equity = 0.34 (Debt 1.09b / totalStockholderEquity, last quarter 3.17b)
Debt / EBITDA = 0.64 (Net Debt 397.3m / EBITDA 623.6m)
Debt / FCF = 3.12 (Net Debt 397.3m / FCF TTM 127.2m)
Total Stockholder Equity = 3.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.61% (Net Income 402.9m / Total Assets 4.81b)
RoE = 12.99% (Net Income TTM 402.9m / Total Stockholder Equity 3.10b)
RoCE = 14.81% (EBIT 603.6m / Capital Employed (Equity 3.10b + L.T.Debt 973.2m))
RoIC = 11.84% (NOPAT 479.3m / Invested Capital 4.05b)
WACC = 8.59% (E(3.72b)/V(4.81b) * Re(9.96%) + D(1.09b)/V(4.81b) * Rd(4.91%) * (1-Tc(0.21)))
Discount Rate = 9.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.44%
[DCF] Terminal Value 67.58% ; FCFF base≈144.9m ; Y1≈95.1m ; Y5≈43.4m
[DCF] Fair Price = 14.43 (EV 769.2m - Net Debt 397.3m = Equity 371.9m / Shares 25.8m; r=8.59% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 7.51 | EPS CAGR: 5.84% | SUE: -0.31 | # QB: 0
Revenue Correlation: 53.50 | Revenue CAGR: 7.96% | SUE: 0.36 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.76 | Chg7d=+0.290 | Chg30d=-0.410 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=13.96 | Chg7d=-0.667 | Chg30d=-0.978 | Revisions Net=-2 | Growth EPS=-5.3% | Growth Revenue=-0.3%
EPS next Year (2027-12-31): EPS=16.18 | Chg7d=-0.133 | Chg30d=+16.177 | Revisions Net=-1 | Growth EPS=+15.9% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -0.5% (Discount Rate 10.0% - Earnings Yield 10.4%)
[Growth] Growth Spread = +2.0% (Analyst 1.5% - Implied -0.5%)